These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15096567)

  • 21. Changes in DNA Level of Oncogenic Human Papillomaviruses Other Than Types 16 and 18 in Relation to Risk of Cervical Intraepithelial Neoplasia Grades 2 and 3.
    Xi LF; Schiffman M; Hughes JP; Galloway DA; Koutsky LA; Kiviat NB
    Cancer Epidemiol Biomarkers Prev; 2019 Aug; 28(8):1388-1394. PubMed ID: 31101617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Viral load of high-risk human papillomaviruses as reliable clinical predictor for the presence of cervical lesions.
    Schmitt M; Depuydt C; Benoy I; Bogers J; Antoine J; Pawlita M; Arbyn M;
    Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):406-14. PubMed ID: 23334590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined human papillomavirus DNA and human papillomavirus-like particle serologic assay to identify women at risk for high-grade cervical intraepithelial neoplasia.
    Einstein MH; Studentsov YY; Ho GY; Fazzari M; Marks M; Kadish AS; Goldberg GL; Runowicz CD; Burk RD
    Int J Cancer; 2007 Jan; 120(1):55-9. PubMed ID: 17036320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Uniplex E6/E7 PCR method detecting E6 or E7 genes in 39 human papillomavirus types.
    Okodo M; Okayama K; Teruya K; Sasagawa T
    J Med Virol; 2018 May; 90(5):981-988. PubMed ID: 29314149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Type-dependent association between risk of cervical intraepithelial neoplasia and viral load of oncogenic human papillomavirus types other than types 16 and 18.
    Fu Xi L; Schiffman M; Ke Y; Hughes JP; Galloway DA; He Z; Hulbert A; Winer RL; Koutsky LA; Kiviat NB
    Int J Cancer; 2017 Apr; 140(8):1747-1756. PubMed ID: 28052328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective evaluation of the Hybrid Capture 2 and AMPLICOR human papillomavirus (HPV) tests for detection of 13 high-risk HPV genotypes in atypical squamous cells of uncertain significance.
    Halfon P; Trepo E; Antoniotti G; Bernot C; Cart-Lamy P; Khiri H; Thibaud D; Marron J; Martineau A; Pénaranda G; Benmoura D; Blanc B;
    J Clin Microbiol; 2007 Feb; 45(2):313-6. PubMed ID: 17122007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sensitivity of APTIMA HPV E6/E7 mRNA test in comparison with hybrid capture 2 HPV DNA test for detection of high risk oncogenic human papillomavirus in 396 biopsy confirmed cervical cancers.
    Basu P; Banerjee D; Mittal S; Dutta S; Ghosh I; Chowdhury N; Abraham P; Chandna P; Ratnam S
    J Med Virol; 2016 Jul; 88(7):1271-8. PubMed ID: 26693677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of human papillomavirus type-16 variants in Italian women with cervical intraepithelial neoplasia and cervical cancer.
    Tornesello ML; Duraturo ML; Salatiello I; Buonaguro L; Losito S; Botti G; Stellato G; Greggi S; Piccoli R; Pilotti S; Stefanon B; De Palo G; Franceschi S; Buonaguro FM
    J Med Virol; 2004 Sep; 74(1):117-26. PubMed ID: 15258977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA-EIA to detect high and low risk HPV genotypes in cervical lesions with E6/E7 primer mediated multiplex PCR.
    Clavel C; Rihet S; Masure M; Chypre C; Boulanger JC; Quereux C; Birembaut P
    J Clin Pathol; 1998 Jan; 51(1):38-43. PubMed ID: 9577370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of E6/E7 mRNA from 'high risk' human papillomavirus in relation to CIN grade, viral load and p16INK4a.
    Andersson S; Hansson B; Norman I; Gaberi V; Mints M; Hjerpe A; Karlsen F; Johansson B
    Int J Oncol; 2006 Sep; 29(3):705-11. PubMed ID: 16865288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection and quantitation of human papillomavirus type 16, 18 and 52 DNA in the peripheral blood of cervical cancer patients.
    Ho CM; Yang SS; Chien TY; Huang SH; Jeng CJ; Chang SF
    Gynecol Oncol; 2005 Dec; 99(3):615-21. PubMed ID: 16099020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.
    Kulasingam SL; Hughes JP; Kiviat NB; Mao C; Weiss NS; Kuypers JM; Koutsky LA
    JAMA; 2002 Oct; 288(14):1749-57. PubMed ID: 12365959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of human papillomavirus on Papanicolaou-stained cervical smears using indirect in situ polymerase chain reaction hybridization.
    Manavi M; Bauer M; Pischinger K; Czerwenka K
    Arch Pathol Lab Med; 2001 Mar; 125(3):353-7. PubMed ID: 11231482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection, genotyping and quantitation of multiple hpv infections in south African women with cervical squamous cell carcinoma.
    Lebelo RL; Bogers JJ; Thys S; Depuydt C; Benoy I; Selabe SG; Bida MN; Mphahlele MJ
    J Med Virol; 2015 Sep; 87(9):1594-600. PubMed ID: 26037775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Detection and genotyping of human papillomavirus (HPV) using PCR-LIS-SSCP].
    Gomez MA; Abba MC; Golijow CD
    Rev Argent Microbiol; 2001; 33(1):22-7. PubMed ID: 11407017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of human papillomavirus type 16 E6/E7 oncogene transcripts in dysplastic and nondysplastic cervical scrapes by nested RT-PCR.
    Sotlar K; Selinka HC; Menton M; Kandolf R; Bültmann B
    Gynecol Oncol; 1998 May; 69(2):114-21. PubMed ID: 9600817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human Papillomavirus infections in Cuban women with cervical intraepithelial neoplasia.
    Soto Y; Mune M; Morales E; Goicolea A; Mora J; Sanchez L; Ramirez R; Alfonso M; Kouri V; Hengge UR
    Sex Transm Dis; 2007 Dec; 34(12):974-6. PubMed ID: 18077849
    [No Abstract]   [Full Text] [Related]  

  • 38. Viral load of episomal and integrated forms of human papillomavirus type 33 in high-grade squamous intraepithelial lesions of the uterine cervix.
    Khouadri S; Villa LL; Gagnon S; Koushik A; Richardson H; Matlashewski G; Roger M; Ferenczy AS; Franco EL; Coutlée F
    Int J Cancer; 2007 Dec; 121(12):2674-81. PubMed ID: 17708553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical validation of the PCR-reverse dot blot human papillomavirus genotyping test in cervical lesions from Chinese women in the Fujian province: a hospital-based population study.
    Sun P; Song Y; Ruan G; Mao X; Kang Y; Dong B; Lin F
    J Gynecol Oncol; 2017 Sep; 28(5):e50. PubMed ID: 28657218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Detection and typing of human papilloma virus by polymerase chain reaction and hybridization assay in cervical samples with cytological abnormalities].
    Ergünay K; Misirlioğlu M; Firat P; Tuncer ZS; Tuncer S; Yildiz I; Ustaçelebi S
    Mikrobiyol Bul; 2008 Apr; 42(2):273-82. PubMed ID: 18697425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.